Inventor
STEVEN NORMAN QUAYLE
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides22%
C07DHeterocyclic compounds11%
PatentTitleYear
12,053,468Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof202411,497,746Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereof202211,337,975Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof202211,324,744Methods of use and pharmaceutical combinations of histone deacetylase inhibitors and CD20 inhibitory antibodies202211,311,540Increasing expression of interferon regulated genes with combinations of histone deacetylase inhibitors and immunomodulatory drugs202211,298,354Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to ACETYLON PHARMACEUTICALS INC (6)· patent assignee history
2022Patents assigned to DANA FARBER CANCER INST INC (1)· patent assignee history
2022–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ACETYLON PHARMACEUTICALS INC | 6 | 2022–2024 |
| DANA FARBER CANCER INST INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2024 |